Patient Insights: EczemaEllen Scheib has had eczema for over twenty years, and though drugs have helped her manage the condition Share XPatient Insights: Eczemahttps://pharmaphorum.com/views-analysis-patients/patient-insights-eczema/
Changing how we talk about clinical trialsMultiple sclerosis (MS) patient Elizabeth Kinder tells us why she participated in a clinical trial and why the Share XChanging how we talk about clinical trialshttps://pharmaphorum.com/views-analysis-patients/changing-talk-clinical-trials-ms/
Words matter during a heart attackRecent research suggests that the ways in which men and women describe heart attack symptoms differently can affect Share XWords matter during a heart attackhttps://pharmaphorum.com/views-analysis-patients/words-matter-during-heart-attack/
Patient Insights: Colorectal CancerEvent planner and colorectal cancer survivor Kim Hall-Jackson tells us how she hopes to improve rates of diagnosis, Share XPatient Insights: Colorectal Cancerhttps://pharmaphorum.com/views-analysis-patients/patient-insights-colorectal-cancer/
Getting MS diagnosis rightMS advocate Trishna Bharadia explains how diagnosis needs to change and why pharma shouldn’t be using the word Share XGetting MS diagnosis righthttps://pharmaphorum.com/views-analysis-patients/getting-ms-diagnosis-right/
Building our own community for an ultra-rare diseaseBo Bigelow shares the story of his daughter Tess, who has an ultra-rare genetic disorder with only 51 Share XBuilding our own community for an ultra-rare diseasehttps://pharmaphorum.com/views-and-analysis/building-our-own-community-for-an-ultra-rare-disease/
Understanding muscular dystrophyChris Anselmo, who has a rare form of muscular dystrophy, hopes to educate pharma on the patient journey Share XUnderstanding muscular dystrophyhttps://pharmaphorum.com/views-analysis-patients/understanding-muscular-dystrophy/
There’s no I in T.E.A.M when it comes to healthcareAfter being diagnosed with a rare non-malignant brain tumour, Claire Snyman has dedicated herself to inspiring people to Share XThere’s no I in T.E.A.M when it comes to healthcarehttps://pharmaphorum.com/views-analysis-patients/theres-no-i-in-t-e-a-m-when-it-comes-to-healthcare/
A blueprint for healthcare: Brand strategy and planningWhen pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital Share XA blueprint for healthcare: Brand strategy and planninghttps://pharmaphorum.com/sales-marketing/a-blueprint-for-healthcare-brand-strategy-and-planning/
